Bioequivalence Study in Healthy Chinese Subjects Comparing SP-01 (Granisetron Patch) Manufactured at Two Different Sites

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 13, 2021

Primary Completion Date

December 3, 2021

Study Completion Date

December 3, 2021

Conditions

Healthy Volunteers

Interventions

DRUG

SP-01 manufactured by Site K (SP-01-K, Transdermal patch contained granisetron)

Single application for 6 days

DRUG

SP-01 manufactured by Site A (SP-01-A, Transdermal patch contained granisetron)

Single application for 6 days

Trial Locations (1)

Phase 1 Clinical Trials Centre, The University of Hong Kong, Hong Kong